Luyan Pharma Co Ltd Total Liabilities
Luyan Pharma Co Ltd total liabilities. Based on the latest financial reports, Luyan Pharma Co Ltd (002788) has total liabilities worth CN¥9.95 Billion CNY (≈ $1.46 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Luyan Pharma Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Luyan Pharma Co Ltd (2011–2025)
Total liabilities of Luyan Pharma Co Ltd from 2011 to 2025. This chart illustrates how Luyan Pharma Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 002788 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Luyan Pharma Co Ltd Competitors by Total Liabilities
The table below lists competitors of Luyan Pharma Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TomTom NV
AS:TOM2
|
Netherlands | €565.10 Million |
|
Lucky Film Co Ltd
SHG:600135
|
China | CN¥478.42 Million |
|
Ur Energy Inc
NYSE MKT:URG
|
USA | $80.27 Million |
|
AB Sagax (publ)
ST:SAGA-D
|
Sweden | Skr49.48 Billion |
|
China Railway Harbin Group of Technology Corp. A
SHG:688459
|
China | CN¥643.36 Million |
|
Changzhou Zhongying Science & Technology Co. Ltd
SHE:300936
|
China | CN¥134.72 Million |
|
Ningbo MedicalSystem Biotechnology Co Ltd
SHE:300439
|
China | CN¥706.76 Million |
|
National Petroleum Co Ltd
TW:9937
|
Taiwan | NT$7.41 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down Luyan Pharma Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Luyan Pharma Co Ltd.
Liquidity & Leverage Metrics
Luyan Pharma Co Ltd Total Liabilities Ratios Explained
Luyan Pharma Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.95 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.75 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Luyan Pharma Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Luyan Pharma Co Ltd (2011–2025)
The table below shows the annual total liabilities of Luyan Pharma Co Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥10.07 Billion ≈ $1.47 Billion |
+6.62% |
| 2024-12-31 | CN¥9.45 Billion ≈ $1.38 Billion |
+7.15% |
| 2023-12-31 | CN¥8.82 Billion ≈ $1.29 Billion |
-1.96% |
| 2022-12-31 | CN¥8.99 Billion ≈ $1.32 Billion |
+21.00% |
| 2021-12-31 | CN¥7.43 Billion ≈ $1.09 Billion |
+23.29% |
| 2020-12-31 | CN¥6.03 Billion ≈ $882.18 Million |
+6.70% |
| 2019-12-31 | CN¥5.65 Billion ≈ $826.77 Million |
+27.92% |
| 2018-12-31 | CN¥4.42 Billion ≈ $646.34 Million |
+23.86% |
| 2017-12-31 | CN¥3.57 Billion ≈ $521.83 Million |
+67.16% |
| 2016-12-31 | CN¥2.13 Billion ≈ $312.17 Million |
-20.49% |
| 2015-12-31 | CN¥2.68 Billion ≈ $392.61 Million |
+0.69% |
| 2014-12-31 | CN¥2.66 Billion ≈ $389.93 Million |
+17.50% |
| 2013-12-31 | CN¥2.27 Billion ≈ $331.85 Million |
+27.67% |
| 2012-12-31 | CN¥1.78 Billion ≈ $259.93 Million |
+82.53% |
| 2011-12-31 | CN¥973.17 Million ≈ $142.40 Million |
-- |
About Luyan Pharma Co Ltd
Luyan Pharma Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products, and prepared slices of traditional Chinese medicine in China. The company distributes medicines, Chinese herbal medicines, medical devices, and others; and provides medical care, elderly care, and wellness services. It also operates pharmaceutical retail ch… Read more